← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 30, 2019Last known activity
Mar 14, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (1 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT05255016Overall official - principal investigatorPhase 2/Phase 3Mar 14, 2022
- NCT03918408Overall official - principal investigatorPhase 1Jun 30, 2019
- NCT03918408Lead sponsorPhase 1Jun 30, 2019
Details
- Last known activity
- Mar 14, 2022